1 Min Read
Sept 18 (Reuters) - Ipsen Sa
* U.S. FDA approves new indication for Ipsen’s somatuline® depot (lanreotide) injection for the treatment of carcinoid syndrome Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.